Immediate versus delayed treatment with Entecavir in patients with active chronic hepatitis B (CHB): impact on liver fibrosis.
Phase of Trial: Phase IV
Latest Information Update: 22 Jun 2013
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 30 Apr 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 17 Jun 2011 New trial record